James E. Norton

1.9k total citations
32 papers, 1.1k citations indexed

About

James E. Norton is a scholar working on Physiology, Otorhinolaryngology and Immunology and Allergy. According to data from OpenAlex, James E. Norton has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 15 papers in Otorhinolaryngology and 12 papers in Immunology and Allergy. Recurrent topics in James E. Norton's work include Asthma and respiratory diseases (21 papers), Sinusitis and nasal conditions (15 papers) and Allergic Rhinitis and Sensitization (12 papers). James E. Norton is often cited by papers focused on Asthma and respiratory diseases (21 papers), Sinusitis and nasal conditions (15 papers) and Allergic Rhinitis and Sensitization (12 papers). James E. Norton collaborates with scholars based in United States, Japan and China. James E. Norton's co-authors include Atsushi Kato, Lydia Suh, Robert P. Schleimer, Bruce K. Tan, Leslie C. Grammer, David B. Conley, Robert C. Kern, Roderick G. Carter, Anju T. Peters and Kathryn E. Hulse and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Journal of Virology.

In The Last Decade

James E. Norton

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James E. Norton United States 19 625 617 532 221 201 32 1.1k
Sudarshan Seshadri United States 11 228 0.4× 163 0.3× 167 0.3× 125 0.6× 237 1.2× 18 622
Tomohisa Iinuma Japan 14 49 0.1× 352 0.6× 280 0.5× 130 0.6× 375 1.9× 38 750
Hsiao Hui Ong Singapore 11 147 0.2× 101 0.2× 88 0.2× 109 0.5× 183 0.9× 27 581
John E. Fitzgerald United States 12 122 0.2× 107 0.2× 35 0.1× 58 0.3× 173 0.9× 21 540
R I Abu-Ghazaleh United States 6 18 0.0× 458 0.7× 166 0.3× 134 0.6× 269 1.3× 6 733
Daljeet Banwatt Canada 15 43 0.1× 134 0.2× 66 0.1× 65 0.3× 684 3.4× 20 945
Helen Fox United Kingdom 11 13 0.0× 1.4k 2.3× 932 1.8× 147 0.7× 276 1.4× 26 1.9k
Anne‐Gaëlle Besnard France 15 18 0.0× 376 0.6× 91 0.2× 645 2.9× 1.2k 6.1× 17 1.7k
Miyuki Omori Japan 11 15 0.0× 713 1.2× 677 1.3× 72 0.3× 850 4.2× 12 1.8k
Paul D. Mehlhop United States 6 9 0.0× 540 0.9× 254 0.5× 84 0.4× 344 1.7× 7 736

Countries citing papers authored by James E. Norton

Since Specialization
Citations

This map shows the geographic impact of James E. Norton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Norton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Norton more than expected).

Fields of papers citing papers by James E. Norton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Norton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Norton. The network helps show where James E. Norton may publish in the future.

Co-authorship network of co-authors of James E. Norton

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Norton. A scholar is included among the top collaborators of James E. Norton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Norton. James E. Norton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erickson, Kristin A., James E. Norton, Jennifer Law, et al.. (2024). Prevention of allergic reactions during oxaliplatin desensitization through inhibition of Bruton tyrosine kinase. Journal of Allergy and Clinical Immunology. 154(1). 222–228.e4. 3 indexed citations
2.
Kato, Atsushi, Katherine A. Naughton, James E. Norton, et al.. (2023). Epigenetic responses to rhinovirus exposure in airway epithelial cells are correlated with key transcriptional pathways in chronic rhinosinusitis. Allergy. 78(10). 2698–2711. 2 indexed citations
3.
Wang, Baofeng, Ping‐Ping Cao, James E. Norton, et al.. (2023). Evidence that oncostatin M synergizes with IL-4 signaling to induce TSLP expression in chronic rhinosinusitis with nasal polyps. Journal of Allergy and Clinical Immunology. 151(5). 1379–1390.e11. 18 indexed citations
4.
Cao, Ping‐Ping, Baofeng Wang, James E. Norton, et al.. (2022). Studies on activation and regulation of the coagulation cascade in chronic rhinosinusitis with nasal polyps. Journal of Allergy and Clinical Immunology. 150(2). 467–476.e1. 2 indexed citations
5.
Kato, Atsushi, Britney A. Helling, James E. Norton, et al.. (2021). Multi-omics colocalization with genome-wide association studies reveals a context-specific genetic mechanism at a childhood onset asthma risk locus. Genome Medicine. 13(1). 157–157. 26 indexed citations
6.
Stevens, Whitney W., Kathryn E. Hulse, Julie A. Poposki, et al.. (2021). Studies of the role of basophils in aspirin-exacerbated respiratory disease pathogenesis. Journal of Allergy and Clinical Immunology. 148(2). 439–449.e5. 29 indexed citations
7.
Stevens, Whitney W., Kathryn E. Hulse, Roderick G. Carter, et al.. (2020). Activation of the 15-lipoxygenase pathway in aspirin-exacerbated respiratory disease. Journal of Allergy and Clinical Immunology. 147(2). 600–612. 59 indexed citations
8.
Imoto, Yoshimasa, Atsushi Kato, Tetsuji Takabayashi, et al.. (2019). Increased thrombin-activatable fibrinolysis inhibitor levels in patients with chronic rhinosinusitis with nasal polyps. Journal of Allergy and Clinical Immunology. 144(6). 1566–1574.e6. 19 indexed citations
9.
Stevens, Whitney W., Anju T. Peters, Lydia Suh, et al.. (2018). Effects of Reslizumab on Nasal Polyp Inflammation in Aspirin Exacerbated Respiratory Disease. Journal of Allergy and Clinical Immunology. 141(2). AB408–AB408. 1 indexed citations
10.
Homma, Tetsuya, Atsushi Kato, Masafumi Sakashita, et al.. (2017). Potential Involvement of the Epidermal Growth Factor Receptor Ligand Epiregulin and Matrix Metalloproteinase-1 in Pathogenesis of Chronic Rhinosinusitis. American Journal of Respiratory Cell and Molecular Biology. 57(3). 334–345. 14 indexed citations
11.
Pothoven, Kathryn L., James E. Norton, Lydia Suh, et al.. (2016). Neutrophils are a major source of the epithelial barrier disrupting cytokine oncostatin M in patients with mucosal airways disease. Journal of Allergy and Clinical Immunology. 139(6). 1966–1978.e9. 115 indexed citations
12.
Homma, Tetsuya, Atsushi Kato, Bharat Bhushan, et al.. (2015). Role of Aspergillus fumigatus in Triggering Protease-Activated Receptor-2 in Airway Epithelial Cells and Skewing the Cells toward a T-helper 2 Bias. American Journal of Respiratory Cell and Molecular Biology. 54(1). 60–70. 30 indexed citations
13.
Stevens, Whitney W., Christopher Ocampo, Sergejs Berdnikovs, et al.. (2015). Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease. American Journal of Respiratory and Critical Care Medicine. 192(6). 682–694. 222 indexed citations
14.
Stevens, Whitney W., Anju T. Peters, Lydia Suh, et al.. (2015). A retrospective, cross‐sectional study reveals that women with CRSwNP have more severe disease than men. Immunity Inflammation and Disease. 3(1). 14–22. 53 indexed citations
15.
Pothoven, Kathryn L., James E. Norton, Kathryn E. Hulse, et al.. (2015). Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease. Journal of Allergy and Clinical Immunology. 136(3). 737–746.e4. 115 indexed citations
16.
Homma, Tetsuya, Atsushi Kato, Masafumi Sakashita, et al.. (2014). Involvement of Toll-Like Receptor 2 and Epidermal Growth Factor Receptor Signaling in Epithelial Expression of Airway Remodeling Factors. American Journal of Respiratory Cell and Molecular Biology. 52(4). 471–481. 10 indexed citations
17.
Bhushan, Bharat, Tetsuya Homma, James E. Norton, et al.. (2014). Suppression of Epithelial Signal Transducer and Activator of Transcription 1 Activation by Extracts of Aspergillus fumigatus. American Journal of Respiratory Cell and Molecular Biology. 53(1). 87–95. 20 indexed citations
19.
Hulse, Kathryn E., James E. Norton, Lydia Suh, et al.. (2013). Chronic rhinosinusitis with nasal polyps is characterized by B-cell inflammation and EBV-induced protein 2 expression. Journal of Allergy and Clinical Immunology. 131(4). 1075–1083.e7. 102 indexed citations
20.
Lytle, Andrew, et al.. (2013). B Cell Infection and Activation by Rabies Virus-Based Vaccines. Journal of Virology. 87(16). 9097–9110. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026